Identification of a Negative Regulatory Domain in the Human Papillomavirus Type 18 Promoter: Interaction with the Transcriptional Repressor YY1

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 1992 Dec 1

PMID 1330541

Citations 68

Authors

T Bauknecht

P Angel

H D Royer

H zur Hausen

Affiliations

Soon will be listed here.

Abstract

The human papillomavirus type 18 (HPV-18) promoter contains a TPA responsive element (TRE) which confers TPA responsiveness on a heterologous promoter. In the context of the HPV-18 promoter, however, this AP-1 site is inactive. We have identified a negative regulatory domain in the HPV-18 promoter which represses the constitutive and TPA-induced AP-1 activity. This negative regulatory sequence has been mapped to 44 nucleotides (OL13). We identified this element as a transcriptional silencer based on its ability to interfere with transcriptional initiation. This HPV-18 silencer domain was narrowed down further to 23 nucleotides, the OL13B element, which bears similarity to three other silencer sequences, present in the mouse N-ras gene upstream regulatory region, the mouse albumin gene enhancer and the adeno-associated virus P5 promoter. The transcriptional repressor protein YY1, which negatively regulates the P5 promoter, binds to the HPV-18 silencer with high affinity. Mutation of the YY1 binding site leads to an enhanced activity of the HPV-18 promoter, strongly suggesting that YY1 plays an important role in controlling HPV-18 early gene expression.

Citing Articles

Insights into expression and localization of HPV16 LCR-associated transcription factors and association with LCR activity in HNSCC.

Aggarwal N, Janjua D, Chaudhary A, Joshi U, Tripathi T, Chandra Keshavam C Mol Ther Oncol. 2025; 33(1):200926.

PMID: 39886356 PMC: 11780949. DOI: 10.1016/j.omton.2024.200926.

Viral oncogene EBNALP regulates YY1 DNA binding and alters host 3D genome organization.

Wang C, Leong M, Ding W, Narita Y, Liu X, Wang H EMBO Rep. 2025; 26(3):810-835.

PMID: 39747661 PMC: 11811279. DOI: 10.1038/s44319-024-00357-6.

Oncogenic Viruses and the Epigenome: How Viruses Hijack Epigenetic Mechanisms to Drive Cancer.

MacLennan S, Marra M Int J Mol Sci. 2023; 24(11).

PMID: 37298494 PMC: 10253656. DOI: 10.3390/ijms24119543.

Dual Role of YY1 in HPV Life Cycle and Cervical Cancer Development.

Warowicka A, Broniarczyk J, Weglewska M, Kwasniewski W, Gozdzicka-Jozefiak A Int J Mol Sci. 2022; 23(7).

PMID: 35408813 PMC: 8998550. DOI: 10.3390/ijms23073453.

Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns.

Aggarwal N, Yadav J, Thakur K, Bibban R, Chhokar A, Tripathi T Front Cell Infect Microbiol. 2020; 10:537650.

PMID: 33344262 PMC: 7738612. DOI: 10.3389/fcimb.2020.537650.

References

zur Hausen H, ONEILL F, Freese U, Hecker E . Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature. 1978; 272(5651):373-5. DOI: 10.1038/272373a0. View

Hariharan N, Kelley D, PERRY R . Delta, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein. Proc Natl Acad Sci U S A. 1991; 88(21):9799-803. PMC: 52808. DOI: 10.1073/pnas.88.21.9799. View

Montalvo E, Shi Y, Shenk T, Levine A . Negative regulation of the BZLF1 promoter of Epstein-Barr virus. J Virol. 1991; 65(7):3647-55. PMC: 241374. DOI: 10.1128/JVI.65.7.3647-3655.1991. View

Shi Y, Seto E, Chang L, Shenk T . Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein. Cell. 1991; 67(2):377-88. DOI: 10.1016/0092-8674(91)90189-6. View

Rosl F, Achtstatter T, Bauknecht T, Hutter K, Futterman G, zur Hausen H . Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions. EMBO J. 1991; 10(6):1337-45. PMC: 452792. DOI: 10.1002/j.1460-2075.1991.tb07653.x. View

Knebel Doeberitz M, Bauknecht T, Bartsch D, zur Hausen H . Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci U S A. 1991; 88(4):1411-5. PMC: 51028. DOI: 10.1073/pnas.88.4.1411. View

Park K, Atchison M . Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site. Proc Natl Acad Sci U S A. 1991; 88(21):9804-8. PMC: 52809. DOI: 10.1073/pnas.88.21.9804. View

Werness B, Levine A, Howley P . Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990; 248(4951):76-9. DOI: 10.1126/science.2157286. View

Thierry F, Dostatni N, Arnos F, Yaniv M . Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance. Mol Cell Biol. 1990; 10(8):4431-7. PMC: 361012. DOI: 10.1128/mcb.10.8.4431-4437.1990. View

10.

Chiu R, Angel P, Karin M . Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell. 1989; 59(6):979-86. DOI: 10.1016/0092-8674(89)90754-x. View

11.

Gentz R, Chen C, Rosen C . Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis. Proc Natl Acad Sci U S A. 1989; 86(3):821-4. PMC: 286569. DOI: 10.1073/pnas.86.3.821. View

12.

Crook T, Morgenstern J, Crawford L, Banks L . Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras. EMBO J. 1989; 8(2):513-9. PMC: 400835. DOI: 10.1002/j.1460-2075.1989.tb03405.x. View

13.

Thierry F, Yaniv M . The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J. 1987; 6(11):3391-7. PMC: 553796. DOI: 10.1002/j.1460-2075.1987.tb02662.x. View

14.

Bos T, Bohmann D, Tsuchie H, Tjian R, Vogt P . v-jun encodes a nuclear protein with enhancer binding properties of AP-1. Cell. 1988; 52(5):705-12. DOI: 10.1016/0092-8674(88)90408-4. View

15.

Schwarz E, Freese U, Gissmann L, Mayer W, Roggenbuck B, Stremlau A . Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985; 314(6006):111-4. DOI: 10.1038/314111a0. View

16.

Paciucci R, Pellicer A . Dissection of the mouse N-ras gene upstream regulatory sequences and identification of the promoter and a negative regulatory element. Mol Cell Biol. 1991; 11(3):1334-43. PMC: 369404. DOI: 10.1128/mcb.11.3.1334-1343.1991. View

17.

Licht J, Grossel M, Figge J, Hansen U . Drosophila Krüppel protein is a transcriptional repressor. Nature. 1990; 346(6279):76-9. DOI: 10.1038/346076a0. View

18.

Romanczuk H, Thierry F, Howley P . Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol. 1990; 64(6):2849-59. PMC: 249467. DOI: 10.1128/JVI.64.6.2849-2859.1990. View

19.

Herbst R, Boczko E, Darnell Jr J, Babiss L . The mouse albumin enhancer contains a negative regulatory element that interacts with a novel DNA-binding protein. Mol Cell Biol. 1990; 10(8):3896-905. PMC: 360900. DOI: 10.1128/mcb.10.8.3896-3905.1990. View

20.

Bernard B, Bailly C, Lenoir M, Darmon M, Thierry F, Yaniv M . The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J Virol. 1989; 63(10):4317-24. PMC: 251048. DOI: 10.1128/JVI.63.10.4317-4324.1989. View